Company
Tune Therapeutics
Mastering the Epigenome
Also known as Tune Therapeutics, Inc.
- Status
- Operatingas of 2026-09-17Source (opens in a new tab)
- Business model
- B2B
- Headquarters
- Durham, NC, United States
- Legal name
- Tune Therapeutics, Inc.
- tunetx.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- X (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
Tune is pioneering a new therapeutic modality that can fine-tune any gene network. In breaking free from the limitations of traditional gene and cell therapies, Tune is developing solutions for even the most challenging and intractable diseases – and building the capacity to transform human health and medicine.
Funding snapshot
- Total raised
- $182MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $182M2023-03-09
Funding rounds
- Round, 2023
- $182M2023-03-09, SEC form D sold, 39 investors
Products
- Other
- TEMPO
- Other
- Tune-401
Loading relationship preview